L-methionase: a therapeutic enzyme to treat malignancies.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4164312)

Published in Biomed Res Int on August 31, 2014

Authors

Bhupender Sharma1, Sukhdev Singh1, Shamsher S Kanwar1

Author Affiliations

1: Department of Biotechnology, Himachal Pradesh University, Summer Hill, Shimla 171 005, India.

Articles cited by this

(truncated to the top 100)

Tissue sulfhydryl groups. Arch Biochem Biophys (1959) 61.89

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 24.57

Mitochondria and apoptosis. Science (1998) 23.41

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res (1988) 9.96

UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science (2007) 7.90

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res (2007) 5.62

The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res (2011) 5.34

DNA methylation and cancer. J Clin Oncol (2004) 4.58

Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol (2005) 4.37

MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science (2007) 4.33

Metabolism of sulfur amino acids in Saccharomyces cerevisiae. Microbiol Mol Biol Rev (1997) 4.11

Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet (2001) 3.58

Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis (2013) 3.07

Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci (2001) 2.99

The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell (2010) 2.97

DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature (2010) 2.74

The specific features of methionine biosynthesis and metabolism in plants. Proc Natl Acad Sci U S A (1998) 2.52

DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) (2004) 1.92

Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res (1996) 1.84

DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene (2011) 1.76

Sulfur metabolism in Escherichia coli and related bacteria: facts and fiction. J Mol Microbiol Biotechnol (2000) 1.75

Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem (2009) 1.70

The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim Biophys Acta (2010) 1.68

Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Mod Pathol (1998) 1.66

Methionine dependency of malignant tumors: a possible approach for therapy. J Natl Cancer Inst (1990) 1.64

Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta (1984) 1.55

Metabolism of sulfur-containing amino acids. Annu Rev Nutr (1986) 1.51

Isolation and purification of L-methionine-alpha-deamino-gamma-mercaptomethane-lyase (L-methioninase) from Clostridium sporogenes. Cancer Res (1973) 1.50

High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci U S A (1976) 1.50

UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell (2014) 1.50

The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci U S A (1974) 1.48

The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle. Oncogene (2005) 1.47

SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin Cancer Res (2012) 1.46

The roles of K(+) channels in cancer. Nat Rev Cancer (2013) 1.46

[37] Reaction of protein sulfhydryl groups with Ellman's reagent. Methods Enzymol (1972) 1.37

On the importance of being zwitterionic: enzymatic catalysis of decarboxylation and deprotonation of cationic carbon. Bioorg Chem (2004) 1.36

Identification and characterization of two isoenzymes of methionine gamma-lyase from Entamoeba histolytica: a key enzyme of sulfur-amino acid degradation in an anaerobic parasitic protist that lacks forward and reverse trans-sulfuration pathways. J Biol Chem (2003) 1.34

Purification and characterization of L-methionine gamma-lyase from brevibacterium linens BL2 Appl Environ Microbiol (1998) 1.33

DNA methylation in early development. Mol Reprod Dev (2010) 1.30

Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci (2014) 1.29

The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis (2012) 1.28

Methionine catabolism in Arabidopsis cells is initiated by a gamma-cleavage process and leads to S-methylcysteine and isoleucine syntheses. Proc Natl Acad Sci U S A (2006) 1.27

Purification and characterization of methionine gamma-lyase from Trichomonas vaginalis. Biochem J (1991) 1.27

Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in p53-null human prostate cancer cells. Oncogene (2006) 1.25

Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochim Biophys Acta (2004) 1.21

Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J Nucl Med (1997) 1.19

Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift. Proc Natl Acad Sci U S A (2011) 1.18

Formation of methyl mercaptan from L-methionine by Porphyromonas gingivalis. Infect Immun (2000) 1.16

Purification of bacterial L-methionine gamma-lyase. Anal Biochem (1984) 1.16

Changes in the expression of methionine adenosyltransferase genes and S-adenosylmethionine homeostasis during hepatic stellate cell activation. Hepatology (2010) 1.13

Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells. Mol Cancer Ther (2006) 1.13

Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol (2010) 1.13

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. Mol Cancer (2009) 1.12

Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies. Eur J Cancer (2004) 1.11

Purification and properties of methioninase from Pseudomonas ovalis. FEBS Lett (1976) 1.11

Methionine dependency and cancer treatment. Cancer Treat Rev (2003) 1.11

Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res (1993) 1.11

Structural analysis of the L-methionine gamma-lyase gene from Pseudomonas putida. J Biochem (1995) 1.10

Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res (1978) 1.10

Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium. Neoplasia (2011) 1.10

UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer (2010) 1.09

Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol (1984) 1.08

Diversity of L-methionine catabolism pathways in cheese-ripening bacteria. Appl Environ Microbiol (2000) 1.07

Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. Int J Cancer (2007) 1.06

Reciprocal modifications of CLIC4 in tumor epithelium and stroma mark malignant progression of multiple human cancers. Clin Cancer Res (2007) 1.05

Influence of methionine/valine-depleted enteral nutrition on nucleic acid and protein metabolism in tumor-bearing rats. World J Gastroenterol (2003) 1.04

CLIC4, an intracellular chloride channel protein, is a novel molecular target for cancer therapy. J Investig Dermatol Symp Proc (2005) 1.03

Glucose transporter-1 expression and prognostic significance in pancreatic carcinogenesis. Histol Histopathol (2009) 1.02

The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun (1983) 1.02

Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B. J Proteome Res (2008) 1.01

The primitive protozoon Trichomonas vaginalis contains two methionine gamma-lyase genes that encode members of the gamma-family of pyridoxal 5'-phosphate-dependent enzymes. J Biol Chem (1998) 1.00

Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth. Cancer Lett (2000) 1.00

Reversible growth arrest in simian virus 40-transformed human fibroblasts. Proc Natl Acad Sci U S A (1980) 1.00

Methioninase cancer gene therapy with selenomethionine as suicide prodrug substrate. Cancer Res (2001) 1.00

Dietary factors and epigenetic regulation for prostate cancer prevention. Adv Nutr (2011) 1.00

Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Mol Cancer Ther (2004) 0.98

Nutrient transporters: the Achilles' heel of anabolism. Trends Endocrinol Metab (2013) 0.98

Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase. Cancer Res (1998) 0.98

Altered methionine metabolism and transmethylation in cancer. Anticancer Res (1985) 0.97

L-methionine degradation potentialities of cheese-ripening microorganisms. J Dairy Res (2001) 0.96

Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res (1993) 0.95

The Roles of the Methyl-CpG Binding Proteins in Cancer. Genes Cancer (2011) 0.94

Benchmark reaction rates, the stability of biological molecules in water, and the evolution of catalytic power in enzymes. Annu Rev Biochem (2011) 0.94

Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice. Clin Cancer Res (1999) 0.94

Overexpression and large-scale production of recombinant L-methionine-alpha-deamino-gamma-mercaptomethane-lyase for novel anticancer therapy. Protein Expr Purif (1997) 0.93

Purification and characterization of methioninase from Pseudomonas putida. J Biochem (1976) 0.93

Dissimilation of methionine by a demethiolase of Aspergillus species. J Bacteriol (1969) 0.92

SGLT gene expression in primary lung cancers and their metastatic lesions. Jpn J Cancer Res (2001) 0.92

Structure of Citrobacter freundii L-methionine gamma-lyase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.92

Effect of nutritional and enzymatic methionine deprivation upon human normal and malignant cells in tissue culture. Cancer Res (1980) 0.91

Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs. Int J Cancer (2009) 0.90

Trifluoromethionine, a prodrug designed against methionine gamma-lyase-containing pathogens, has efficacy in vitro and in vivo against Trichomonas vaginalis. Antimicrob Agents Chemother (2001) 0.90

Tumor therapy by deprivation of L-methionine: rationale and results. Cancer Treat Rep (1979) 0.90

ATP consumption promotes cancer metabolism. Cell (2010) 0.89

Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers. J Natl Cancer Inst (2002) 0.88

Gene cloning and characterization of Pseudomonas putida L-methionine-alpha-deamino-gamma-mercaptomethane-lyase. Cancer Res (1996) 0.88

Structure of the antitumour enzyme L-methionine gamma-lyase from Pseudomonas putida at 1.8 A resolution. J Biochem (2007) 0.87

Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation. Br J Cancer (1997) 0.87

Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes. J Nutr (2009) 0.87

Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells In Vitro. Anticancer Res (2010) 0.87